Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > State of affairs
View:
Post by jmm1228 on Nov 28, 2023 11:43am

State of affairs

TlLT's premier investor is also CEO.  It is unconscionable to me that he will not protect his baby, whatever it takes. Thus covering us frazzled holders too.

He, like many of us, is underwater on his holding - likely the largest of all stakes held here.

No matter how dire the the on-going T LT situation becomes he will find a way to protect his interest, thus ours, IMO.

Ialso sense that  the prime reasons TLT has a low market cap versus the potential is three-fold. Being listed on the TVX, nervous financial advisor support and hand to mouth, weak, seemingly last resort, financing tactics.

Invariably, upon telling friends and family to consider taking a position, I am told that their financial advisors have sternly waved them off.

Congrats to those wh have the guts and patience to get and stay aboard. 

One of these days our time will come.
Comment by Galaxym31 on Nov 28, 2023 11:50am
Maybe .
Comment by Legit62 on Nov 28, 2023 12:09pm
Great post jm1228,agree with you, he wont let this slip away since he is one of the few that actually know the behind the scenes workings, if we dont see a big pony up it could spell trouble,IMO He has to know FDAs stance so time will tell
Comment by gebremeskel on Nov 28, 2023 1:31pm
Can't disagree with that jmm. By my calculations, if the stock price went up to $5/share, Roger's holdings (including options and warrants) would be worth $88 M and Kristina's $39 M - and if the sp hits $10 it would be Roger $175 M and Kristina $77 M. I'd call that having skin in the game! I sincerely doubt there is anybody on this board who wants this to happen more than they do ...more  
Comment by Oilminerdeluxe on Nov 28, 2023 2:34pm
Tremendous volumes traded thus far. Could we get an actual zero trade day
Comment by Legit62 on Nov 28, 2023 3:26pm
Alot of waiting going on now, 40,000 US shares, when news comes out we should see bigger uptick in volume. Transparency and news will move us, faullted timelines no
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250